Novel inhibition of contractility by wortmannin in skeletal muscle

British Journal of Pharmacology

Volumn 124, Issue 5, 1998, Pages 849-856

  Hong, S J ^a   Chang, C C ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Excitation contraction coupling; Phosphatidylinositol positive inotropic effect; Rapamycin; Ryanodine receptor; Wortmannin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CAFFEINE; CALCIUM ION; CROTAMINE; MYCOTOXIN; RYANODINE; TRANSFERASE INHIBITOR; WORTMANNIN;

ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CELL MEMBRANE DEPOLARIZATION; DRUG INHIBITION; INOTROPISM; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTILITY; MUSCLE TONE; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACTION POTENTIALS; ANDROSTADIENES; ANIMALS; CAFFEINE; CHROMONES; DIRECT LYTIC FACTORS; ENZYME INHIBITORS; HEART; MICE; MICE, INBRED ICR; MORPHOLINES; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYOCARDIAL CONTRACTION; NEUROMUSCULAR JUNCTION; POLYENES; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; RYANODINE; SIROLIMUS; SODIUM CHANNELS; STIMULATION, CHEMICAL;

EID: 0031838486     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701898     Document Type: Article

References (37)

1. AHERN, G.P., JUNANKAR, P.R. & DULHUNTY, A.F. (1997). Ryanodine receptors from rabbit skeletal muscle are reversibly activated by rapamycin. Neurosci. Lett., 225, 81-84.
2. ARCARO, A. & WYMANN, M.P. (1993). Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem. J., 296, 297-301.
3. BRILLANTES, A.-M.B., ONDRIAŠ, K., SCOTT, A., KOBRINSKY, E., ONDRIAŠOVÁ, E., MOSCHELLA, M.C., JAYARAMAN, T., LANDERS, M., EHRLICH, B.E. & MARKS, A.R. (1994). Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell, 77, 513-523.
4. BURKE, E.P., GERTHOFFER, W.T., SANDERS, K.M. & PUBLICOVER, N.G. (1996). Wortmannin inhibits contraction without altering electrical activity in canine gastric smooth muscle. Am. J. Physiol., 270, C1405-C1412.
5. CANNELL, M.B., CHENG, H. & LEDERER, W.J. (1995). The control of calcium release in heart muscle. Science, 268, 1045-1049.
6. CHANG, C.C. (1979). The action of snake venoms on nerve and muscle. In Snake Venoms, ed. Lee, C.Y. Handb. Exp. Pharmacol., vol. 52, pp. 309-376. Berlin: Springer-Verlag.
7. CHANG, C.C., CHIOU, L.C., HWANG, L.L., HONG, S.J. & HUANG, C.Y. (1989). Nicardipine inhibits axon conduction but causes dual changes of acetylcholine release in the mouse motor nerve. Can. J. Physiol. Pharmacol., 67, 1493-1498.
8. DULHUNTY, A.F. & GAGE, P.W. (1988). Effects of extracellular calcium concentration and dihydropyridines on contraction in mammalian skeletal muscle. J. Physiol., 399, 63-80.
9. EISENBERG, R.S., MCCARTHY, R.T. & MILTON, R.L. (1983). Paralysis of frog skeletal muscle fibres by the calcium antagonist D-600. J. Physiol., 341, 495-505.
10. FRANZINI-ARMSTRONG, C. & PROTASI, F. (1997). Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol. Rev., 77, 699-729.
11. HONG, S.J. & CHANG, C.C. (1983). Potentiation by crotamine of the depolarizing effects of batrachotoxin, protoveratrine A and grayanotoxin I on the rat diaphragm. Toxicon, 21, 503-514.
12. HOWLETT, S.E. & FERRIER, G.R. (1997). The voltage-sensitive release mechanism: a new trigger for cardiac contraction. Can. J. Physiol. Pharmacol., 75, 1044-1057.
13. HUI, C.S., MILTON, R.L. & EISENBERG, R.S. (1984). Charge movement in skeletal muscle fibers paralyzed by the calcium-entry blocker D600. Proc. Natl. Acad. Sci. U.S.A., 81, 2582-2585.
14. JAYARAMAN, T., BRILLANTES, A.-M., TIMERMAN, A.P., FLEISCHER, S., ERDJUMENT-BROMAGE, H., TEMPST, P. & MARKS, A.R. (1992). FK506 binding protein associated with the calcium release channel (ryanodine receptor). J. Biol. Chem., 267, 9474-9477.
15. KALIMAN, P., VIÑALS, F., TESTAR, X., PALACÍN, M. & ZORZANO, A. (1996). Phosphatidylinositol 3-kinase inhibitors block differentiation of skeletal muscle cells. J. Biol. Chem., 271, 19146-19151.
16. LAMB, G.D. & STEPHENSON, D.G. (1996). Effects of FK506 and rapamycin on excitation-contraction coupling in skeletal muscle fibres of the rat. J. Physiol., 494, 569-576.
17. MACLENNAN, D.H. & PHILLIPS, M.S. (1992). Malignant hyperthermia. Science, 256, 789-794.
18. MARTY, I., ROBERT, M., VILLAZ, M., DE JONGH, K.S., LAI, Y., CATTERALL, W.A. & RONJAT, M. (1994). Biochemical evidence for a complex involving dihydropyridine receptor and ryanodine receptor in triad junctions of skeletal muscle. Proc. Natl. Acad. Sci. U.S.A., 91, 2270-2274.
19. 2+ regulation defects. Physiol. Rev., 76, 537-592.
20. NAKAI, J., OGURA, T., PROTASI, F., FRANZINI-ARMSTRONG, C., ALLENS, P.D. & BEAM, K.G. (1997). Functional nonequality of the cardiac and skeletal ryanodine receptors. Proc. Natl. Acad. Sci. U.S.A., 94, 1019-1022.
21. NAKANISHI, S., KAKITA, S., TAKAHASHI, I., KAWAHARA, K., TSUKUDA, E., SANO, T., YAMADA, K., YOSHIDA, M., KASE, H. & MATSUDA, Y. (1992). Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem., 267, 2157-2163.
22. 2+ current in frog skeletal muscle fibres. J. Physiol., 427, 187-209.
23. 2+ release from sarcoplasmic reticulum in guinea pig skeletal muscle. Eur. J. Pharmacol., 178, 11-19.
24. POWIS, G., BONJOUKLIAN, R., BERGGREN, M.M., GALLEGOS, A., ABRAHAM, R., ASHENDEL, C., ZALKOW, L., MATTER, W.F., DODGE, J., GRINDEY, G. & VLAHOS, C.J. (1994). Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res., 54, 2419-2423.
25. RİOS, E., KARHANEK, M., MA, J. & GONZÁLEZ, A. (1993). An allosteric model of the molecular interactions of excitation-contraction coupling in skeletal muscle. J. Gen. Physiol., 102, 449-481.
26. SCHNEIDER, M.F. (1994). Control of calcium release in functioning skeletal muscle fibers. Annu. Rev. Physiol., 56, 463-484.
27. SOMLYO, A.P. & SOMLYO, A.V. (1994). Signal transduction and regulation in smooth muscle. Nature, 372, 231-236.
28. 2+ release channels: does diversity in form equal diversity in function? Physiol. Rev., 76, 1027-1071.
29. SWEENEY, H.L., BOWMAN, B.F. & STULL, J.T. (1993). Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. Am. J. Physiol., 264, C1085-C1095.
30. 2+ levels, myosin light chain phosphorylation and force in vascular smooth muscle. Naunyn-Schmiedeberg's Arch. Pharmacol., 354, 120-127.
31. TIMERMAN, A.P., OGUNBUMNI, E., FREUND, E., WIEDERRECHT, G., MARKS, A.R. & FLEISCHER, S. (1993). The calcium release channel of sarcoplasmic reticulum is modulated by FK-506-binding protein. J. Biol. Chem., 268, 22992-22999.
32. UI, M., OKADA, T., HAZEKI, K. & HAZEKI, O. (1995). Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biol. Sci., 20, 303-307.
33. VLAHOS, C.J., MATTER, W.F., HUI K.Y. & BROWN, R.E. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem., 269, 5241-5248.
34. WAGENKNECHT, T., GRASSUCCI, R., BERKOWITZ, J., WIEDERRECHT, G.J., XIN, H.-B. & FLEISCHER, S. (1996). Cryoelectron microscopy resolves FK506-binding protein sites on the skeletal muscle ryanodine receptor. Biophys. J., 70, 1709-1715.
35. WOJTASZEWSKI, J.F.P., HANSEN, B.F., URSO, B. & RICHTER, E.A. (1996). Wortmannin inhibits both insulin- and contraction-stimulated glucose uptake and transport in rat skeletal muscle. J. Appl. Physiol., 81, 1501-1509.
36. XU, L., JONES, R. & MEISSNER, G. (1993). Effects of local anesthetics on single channel behavior of skeletal muscle calcium release channel. J. Gen. Physiol., 101, 207-233.
37. 2+ channel/ryanodine receptor: modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev., 49, 1-51.